174 related articles for article (PubMed ID: 37623652)
21. Dual-Receptor-Targeted (DRT) Radiation Nanomedicine Labeled with
Yook S; Cai Z; Jeong JJ; Lu Y; Winnik MA; Pignol JP; Reilly RM
Mol Pharm; 2020 Apr; 17(4):1226-1236. PubMed ID: 32022567
[TBL] [Abstract][Full Text] [Related]
22. Electrostatically bound lanreotide peptide - gold nanoparticle conjugates for enhanced uptake in SSTR2-positive cancer cells.
Shelar SB; Gawali SL; Barick KC; Kunwar A; Mohan A; Priyadarsini IK; Hassan PA
Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111272. PubMed ID: 32919636
[TBL] [Abstract][Full Text] [Related]
23. Colloidal gold nanoparticle conjugates of gefitinib.
Lam AT; Yoon J; Ganbold EO; Singh DK; Kim D; Cho KH; Lee SY; Choo J; Lee K; Joo SW
Colloids Surf B Biointerfaces; 2014 Nov; 123():61-7. PubMed ID: 25216919
[TBL] [Abstract][Full Text] [Related]
24. Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model.
Kao HW; Lin YY; Chen CC; Chi KH; Tien DC; Hsia CC; Lin WJ; Chen FD; Lin MH; Wang HE
Nanotechnology; 2014 Jul; 25(29):295102. PubMed ID: 24990295
[TBL] [Abstract][Full Text] [Related]
25. Tethering of spherical DOTAP liposome gold nanoparticles on cysteamine monolayer for sensitive label free electrochemical detection of DNA and transfection.
Bhuvana M; Dharuman V
Analyst; 2014 May; 139(10):2467-75. PubMed ID: 24652193
[TBL] [Abstract][Full Text] [Related]
26. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
[TBL] [Abstract][Full Text] [Related]
27. β-Lactoglobulin-gold nanoparticles interface and its interaction with some anticancer drugs - an approach for targeted drug delivery.
Waghmare MN; Qureshi TS; Krishna CM; Pansare K; Gadewal N; Hole A; Dongre PM
J Biomol Struct Dyn; 2022 Aug; 40(13):6193-6210. PubMed ID: 33509048
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of two folate-conjugated gold nanoparticles for cancer nanotechnology applications.
Mansoori GA; Brandenburg KS; Shakeri-Zadeh A
Cancers (Basel); 2010 Nov; 2(4):1911-28. PubMed ID: 24281209
[TBL] [Abstract][Full Text] [Related]
29. Gallic acid conjugated with gold nanoparticles: antibacterial activity and mechanism of action on foodborne pathogens.
Rattanata N; Klaynongsruang S; Leelayuwat C; Limpaiboon T; Lulitanond A; Boonsiri P; Chio-Srichan S; Soontaranon S; Rugmai S; Daduang J
Int J Nanomedicine; 2016; 11():3347-56. PubMed ID: 27555764
[TBL] [Abstract][Full Text] [Related]
30. Anticancer activity of gold nanobioconjugates synthesized from
Shinde AS; Mendhulkar VD
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147946
[TBL] [Abstract][Full Text] [Related]
31. Kit for preparation of multimeric receptor-specific ⁹⁹mTc-radiopharmaceuticals based on gold nanoparticles.
Ocampo-García B; Ferro-Flores G; Morales-Avila E; Ramírez Fde M
Nucl Med Commun; 2011 Nov; 32(11):1095-104. PubMed ID: 21860334
[TBL] [Abstract][Full Text] [Related]
32. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.
Oh E; Delehanty JB; Sapsford KE; Susumu K; Goswami R; Blanco-Canosa JB; Dawson PE; Granek J; Shoff M; Zhang Q; Goering PL; Huston A; Medintz IL
ACS Nano; 2011 Aug; 5(8):6434-48. PubMed ID: 21774456
[TBL] [Abstract][Full Text] [Related]
33. Formulation of Ceftriaxone Conjugated Gold Nanoparticles and Their Medical Applications against Extended-Spectrum β-Lactamase Producing Bacteria and Breast Cancer.
Gad El-Rab SMF; Halawani EM; Hassan A
J Microbiol Biotechnol; 2018 Sep; 28(9):1563-1572. PubMed ID: 30369118
[TBL] [Abstract][Full Text] [Related]
34. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231).
Balakrishnan S; Mukherjee S; Das S; Bhat FA; Raja Singh P; Patra CR; Arunakaran J
Cell Biochem Funct; 2017 Jun; 35(4):217-231. PubMed ID: 28498520
[TBL] [Abstract][Full Text] [Related]
35. Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab.
Yousefpour P; Atyabi F; Vasheghani-Farahani E; Movahedi AA; Dinarvand R
Int J Nanomedicine; 2011; 6():1977-90. PubMed ID: 21976974
[TBL] [Abstract][Full Text] [Related]
36. Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging.
Mendoza-Sánchez AN; Ferro-Flores G; Ocampo-García BE; Morales-Avila E; de M Ramírez F; De León-Rodríguez LM; Santos-Cuevas CL; Medina LA; Rojas-Calderón EL; Camacho-López MA
J Biomed Nanotechnol; 2010 Aug; 6(4):375-84. PubMed ID: 21323111
[TBL] [Abstract][Full Text] [Related]
37. Antibody-functionalized gold nanoparticles as tumor-targeting radiosensitizers for proton therapy.
Li S; Bouchy S; Penninckx S; Marega R; Fichera O; Gallez B; Feron O; Martinive P; Heuskin AC; Michiels C; Lucas S
Nanomedicine (Lond); 2019 Feb; 14(3):317-333. PubMed ID: 30675822
[TBL] [Abstract][Full Text] [Related]
38. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis.
Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I
Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
